Pre-Spend Diagnostic

Technical Specification

1. Definition

The Pre-Spend Diagnostic is a patented quantitative behavioural diagnostic of trust in the buying journey, run before marketing budget is committed.

It operationalises structured marketing due diligence through behavioural measurement across six defined Trust Checkpoints.

2. Purpose

The Pre-Spend Diagnostic exists to:

  • Quantify structural trust integrity prior to capital deployment

  • Identify checkpoint instability that increases risk exposure

  • Evaluate revenue feasibility relative to declared targets

  • Govern marketing budget approval decisions

The diagnostic functions as a pre-spend decision control mechanism.

It does not prescribe marketing tactics or execution strategy.

3. Scope

The Pre-Spend Diagnostic applies prior to:

  • Approval of new marketing budgets

  • Increases to existing marketing budgets

  • Agency scoping or briefing

  • Rebrand initiation

  • Campaign launch

  • Board-level budget signoff

  • Marketing-dependent capital raising

  • Marketing-linked loan applications

  • Expansion of paid acquisition channels

The diagnostic must be conducted before capital deployment.
Post-spend evaluation does not constitute pre-spend governance.

4. Required Inputs

The Pre-Spend Diagnostic requires behavioural and commercial inputs sufficient to evaluate structural performance across all six Trust Checkpoints.

4.1 Behavioural Inputs (Minimum Required – Last Representative 30 Days)

  • Site visitors

  • Bounce rate

  • Average time on site

  • Pages per session

  • Percentage of new users

These inputs inform performance at:

  • The Arrival

  • The First Impression

  • The First Date

4.2 Commercial and Conversion Inputs

  • Target revenue per month (aspirational)

  • Average buy size (contract value or AOV)

  • Number of buyers in the period

  • Number of sign-ups (Honeymoon checkpoint)

  • Number engaged within 48 hours (Reality checkpoint)

These inputs inform:

  • Conversion stability

  • Early retention integrity

  • Revenue feasibility modelling

4.3 Decision Trigger Declaration (Mandatory)

The diagnostic requires declaration of the decision under consideration.

Examples include:

  • Approval of new marketing budget

  • Increase to existing marketing budget

  • Agency brief preparation

  • Rebrand initiation

  • Campaign performance review

  • Board-level reporting

  • Loan due diligence

A Pre-Spend Diagnostic conducted without declared decision context is incomplete.

5. Structural Model

The Pre-Spend Diagnostic evaluates performance across six Trust Checkpoints:

  1. The Arrival

  2. The First Impression

  3. The First Date

  4. The Honeymoon

  5. The Reality

  6. The Moment of Truth

Each Trust Checkpoint:

  • Has a defined stability threshold

  • Contributes to the overall Buyer Trust Score

  • Influences revenue feasibility modelling

The diagnostic operates under a proprietary weighted scoring model.

Weighting reflects the relative structural contribution of each checkpoint to revenue stability and risk exposure.

Detailed weighting logic and threshold calibration remain proprietary.

6. Outputs

The Pre-Spend Diagnostic produces the following outputs:

6.1 Buyer Trust Score (BTS)

A weighted composite index (0–100) measuring aggregate behavioural certainty across the six Trust Checkpoints.

The Buyer Trust Score:

  • Incorporates checkpoint stability thresholds

  • Reflects structural integrity

  • May be constrained by material checkpoint failure

6.2 Revenue Feasibility Index (RFI)

A probability-adjusted index (0–100) estimating whether declared revenue targets are structurally achievable without amplifying instability.

The Revenue Feasibility Index informs capital allocation decisions.

6.3 Checkpoint Stability Scores

Each Trust Checkpoint receives:

  • A numerical stability score (0–100)

  • Threshold comparison

  • Structural risk interpretation

6.4 Verdict Protocol

Every Pre-Spend Diagnostic resolves into four structured verdicts:

STOP
KEEP
FIX
PROVE

No additional categories are permitted.

7. Threshold Governance Model

The Pre-Spend Diagnostic operates under a threshold-constrained governance model.

Principles:

  • Each Trust Checkpoint has a defined minimum stability requirement.

  • Deviation from threshold increases structural risk.

  • Material failure in critical checkpoints may constrain overall Buyer Trust Score.

  • Capital deployment must not precede structural validation.

Threshold values and constraint logic are proprietary.

8. Re-Validation Requirement (PROVE)

Structural corrections must be validated through re-execution of the Pre-Spend Diagnostic, or the relevant checkpoint diagnostic, after a minimum seven-day operational period.

Capital expansion must not occur until re-run results demonstrate improved stability in the affected checkpoint.

Partial, selective, or self-reported metrics do not constitute validation.

9. Execution Boundary

The Pre-Spend Diagnostic governs decisions.

Execution support tools operate downstream and do not influence:

  • Score calculation

  • Weighting logic

  • Threshold determination

  • Verdict output

The Pre-Spend Diagnostic is not a marketing agency service.

10. Intellectual Property

RAMMP is protected by granted patents in Australia and New Zealand, with patent pending in the United States.

The Pre-Spend Diagnostic methodology is protected intellectual property.

11. Version Control

Pre-Spend Diagnostic Specification
Version 1.0
Last Updated: 2026-02-19

Future revisions will be versioned and archived.